Cellid, Co., Ltd. (KOSDAQ:299660)
South Korea
· Delayed Price · Currency is KRW 5,810.00
-220.00 (-3.65%)
Jun 19, 2025, 3:30 PM KST
Cellid, Market Cap
Cellid, has a market cap or net worth of 122.61 billion as of June 18, 2025. Its market cap has increased by 139.40% in one year.
Market Cap
122.61B
Enterprise Value
127.18B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5,810.00
Market Cap Chart
Since February 20, 2019, Cellid,'s market cap has decreased from 482.44B to 122.61B, a decrease of -74.59%. That is a compound annual growth rate of -19.46%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.89T |
| Celltrion | 35.78T |
| ALTEOGEN | 21.24T |
| Yuhan | 7,785.95B |
| SK Biopharmaceuticals | 7,134.34B |
| HLB Co., Ltd. | 6,676.37B |
| Peptron | 4,407.86B |
| PharmaResearch | 4,363.65B |